259 related articles for article (PubMed ID: 21070604)
1. Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression.
Lo DJ; Weaver TA; Stempora L; Mehta AK; Ford ML; Larsen CP; Kirk AD
Am J Transplant; 2011 Jan; 11(1):22-33. PubMed ID: 21070604
[TBL] [Abstract][Full Text] [Related]
2. Belatacept-Resistant Rejection Is Associated With CD28
Mathews DV; Wakwe WC; Kim SC; Lowe MC; Breeden C; Roberts ME; Farris AB; Strobert EA; Jenkins JB; Larsen CP; Ford ML; Townsend R; Adams AB
Am J Transplant; 2017 Sep; 17(9):2285-2299. PubMed ID: 28502128
[TBL] [Abstract][Full Text] [Related]
3. Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion.
Lo DJ; Anderson DJ; Weaver TA; Leopardi F; Song M; Farris AB; Strobert EA; Jenkins J; Turgeon NA; Mehta AK; Larsen CP; Kirk AD
Am J Transplant; 2013 Feb; 13(2):320-8. PubMed ID: 23311611
[TBL] [Abstract][Full Text] [Related]
4. Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates.
Weaver TA; Charafeddine AH; Agarwal A; Turner AP; Russell M; Leopardi FV; Kampen RL; Stempora L; Song M; Larsen CP; Kirk AD
Nat Med; 2009 Jul; 15(7):746-9. PubMed ID: 19584865
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells control alloreactive CD8(+) CD28(-) T cells.
Engela AU; Baan CC; Litjens NH; Franquesa M; Betjes MG; Weimar W; Hoogduijn MJ
Clin Exp Immunol; 2013 Dec; 174(3):449-58. PubMed ID: 24028656
[TBL] [Abstract][Full Text] [Related]
6. Increased Pretransplant Frequency of CD28
Cortes-Cerisuelo M; Laurie SJ; Mathews DV; Winterberg PD; Larsen CP; Adams AB; Ford ML
Am J Transplant; 2017 Sep; 17(9):2350-2362. PubMed ID: 28502091
[TBL] [Abstract][Full Text] [Related]
7. mTOR Inhibitor Therapy Diminishes Circulating CD8+ CD28- Effector Memory T Cells and Improves Allograft Inflammation in Belatacept-refractory Renal Allograft Rejection.
Castro-Rojas CM; Godarova A; Shi T; Hummel SA; Shields A; Tremblay S; Alloway RR; Jordan MB; Woodle ES; Hildeman DA
Transplantation; 2020 May; 104(5):1058-1069. PubMed ID: 31415033
[TBL] [Abstract][Full Text] [Related]
8. Belatacept and sirolimus prolong nonhuman primate islet allograft survival: adverse consequences of concomitant alefacept therapy.
Lowe MC; Badell IR; Turner AP; Thompson PW; Leopardi FV; Strobert EA; Larsen CP; Kirk AD
Am J Transplant; 2013 Feb; 13(2):312-9. PubMed ID: 23279640
[TBL] [Abstract][Full Text] [Related]
9. Alefacept promotes immunosuppression-free renal allograft survival in nonhuman primates via depletion of recipient memory T cells.
Lee S; Yamada Y; Tonsho M; Boskovic S; Nadazdin O; Schoenfeld D; Cappetta K; Atif M; Smith RN; Cosimi AB; Benichou G; Kawai T
Am J Transplant; 2013 Dec; 13(12):3223-9. PubMed ID: 24165326
[TBL] [Abstract][Full Text] [Related]
10. Selective CD28 blockade attenuates CTLA-4-dependent CD8+ memory T cell effector function and prolongs graft survival.
Liu D; Badell IR; Ford ML
JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321374
[TBL] [Abstract][Full Text] [Related]
11. Siplizumab combination therapy with belatacept or abatacept broadly inhibits human T cell alloreactivity in vitro.
Cvetkovski F; Razavi R; Sellberg F; Berglund E; Berglund D
Am J Transplant; 2023 Oct; 23(10):1603-1611. PubMed ID: 37270108
[TBL] [Abstract][Full Text] [Related]
12. A pilot trial targeting the ICOS-ICOS-L pathway in nonhuman primate kidney transplantation.
Lo DJ; Anderson DJ; Song M; Leopardi F; Farris AB; Strobert E; Chapin S; Devens B; Karrer E; Kirk AD
Am J Transplant; 2015 Apr; 15(4):984-92. PubMed ID: 25703015
[TBL] [Abstract][Full Text] [Related]
13. Selective blockade of CD28 and not CTLA-4 with a single-chain Fv-alpha1-antitrypsin fusion antibody.
Vanhove B; Laflamme G; Coulon F; Mougin M; Vusio P; Haspot F; Tiollier J; Soulillou JP
Blood; 2003 Jul; 102(2):564-70. PubMed ID: 12649149
[TBL] [Abstract][Full Text] [Related]
14. Down-Regulation of Surface CD28 under Belatacept Treatment: An Escape Mechanism for Antigen-Reactive T-Cells.
de Graav GN; Hesselink DA; Dieterich M; Kraaijeveld R; Weimar W; Baan CC
PLoS One; 2016; 11(2):e0148604. PubMed ID: 26919152
[TBL] [Abstract][Full Text] [Related]
15. IL-15 induces alloreactive CD28(-) memory CD8 T cell proliferation and CTLA4-Ig resistant memory CD8 T cell activation.
Traitanon O; Gorbachev A; Bechtel JJ; Keslar KS; Baldwin WM; Poggio ED; Fairchild RL
Am J Transplant; 2014 Jun; 14(6):1277-89. PubMed ID: 24842641
[TBL] [Abstract][Full Text] [Related]
16. Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients.
Xu H; Samy KP; Guasch A; Mead SI; Ghali A; Mehta A; Stempora L; Kirk AD
Am J Transplant; 2016 Feb; 16(2):550-64. PubMed ID: 26436448
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of Belatacept on virus-specific memory versus de novo allo-specific T cell responses of kidney transplant recipients and healthy donors.
Kühne JF; Neudörfl C; Beushausen K; Keil J; Malysheva S; Wandrer F; Haller H; Messerle M; Blume C; Neuenhahn M; Schlott F; Hammerschmidt W; Zeidler R; Falk CS
Transpl Immunol; 2020 Aug; 61():101291. PubMed ID: 32330566
[TBL] [Abstract][Full Text] [Related]
18. Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection.
Kim EJ; Kwun J; Gibby AC; Hong JJ; Farris AB; Iwakoshi NN; Villinger F; Kirk AD; Knechtle SJ
Am J Transplant; 2014 Jan; 14(1):59-69. PubMed ID: 24354871
[TBL] [Abstract][Full Text] [Related]
19. The Effect of ASP2409, a Novel CD86-Selective Variant of CTLA4-Ig, on Renal Allograft Rejection in Nonhuman Primates.
Oshima S; Karrer EE; Kawato Y; Maeda M; Fukahori H; Tsujimoto S; Hirose J; Nakamura K; Marui T; Takamura F; Noto T; Chapin SJ; Fujii Y; Neighbors M; Viswanathan S; Devens BH; Higashi Y
Transplantation; 2016 Dec; 100(12):2611-2620. PubMed ID: 27861289
[TBL] [Abstract][Full Text] [Related]
20. Novel insight into the agonistic mechanism of alefacept in vivo: differentially expressed genes may serve as biomarkers of response in psoriasis patients.
Haider AS; Lowes MA; Gardner H; Bandaru R; Darabi K; Chamian F; Kikuchi T; Gilleaudeau P; Whalen MS; Cardinale I; Novitskaya I; Krueger JG
J Immunol; 2007 Jun; 178(11):7442-9. PubMed ID: 17513795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
